These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6692648)

  • 41. [Treatment of peritonitis under continuous ambulatory peritoneal dialysis using intraperitoneal ceftazidime].
    Ragnaud JM; Dupon M; Morlat P; Bezian MC; Wone C
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):681-4. PubMed ID: 2677930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of once daily intra-peritoneal aztreonam and vancomycin in the treatment of CAPD peritonitis.
    Brown J; Altmann P; Cunningham J; Shaw E; Marsh F
    J Antimicrob Chemother; 1990 Jan; 25(1):141-7. PubMed ID: 2318749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of peritonitis on the transperitoneal transport of cefuroxime in patients on CAPD treatment.
    Dahl K; Walstad RA; Widerøe TE
    Nephrol Dial Transplant; 1990; 5(4):275-81. PubMed ID: 2113224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis.
    Whitby M; Edwards R; Aston E; Finch RG
    J Antimicrob Chemother; 1987 Mar; 19(3):351-7. PubMed ID: 3571051
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic studies of cefoxitin in continuous ambulatory peritoneal dialysis.
    Arvidsson A; Alván G; Tranaeus A; Malmborg AS
    Eur J Clin Pharmacol; 1985; 28(3):333-7. PubMed ID: 4007038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of peritonitis due to continuous ambulatory peritoneal dialysis using a single daily intraperitoneal dose of 1g cefotiam].
    Ragnaud JM; Roche-Bezian MC; Marceau C; Demothes-Mainard F; Albin H; Prevost D; Wone C
    Pathol Biol (Paris); 1986 May; 34(5):512-6. PubMed ID: 3534734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of serum vancomycin concentrations following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis.
    Bailie GR; Eisele G; Venezia RA; Yocum D; Hollister A
    Clin Pharmacokinet; 1992 Apr; 22(4):298-307. PubMed ID: 1606789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disposition of cefotaxime and desacetyl cefotaxime during continuous ambulatory peritoneal dialysis.
    Heim KL; Halstenson CE; Comty CM; Affrime MB; Matzke GR
    Antimicrob Agents Chemother; 1986 Jul; 30(1):15-9. PubMed ID: 3752976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis.
    Bowley JA; Pickering SJ; Scantlebury AJ; Ackrill P; Jones DM
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():133-9. PubMed ID: 2965125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ciprofloxacin in plasma and peritoneal dialysate after oral therapy in patients on continuous ambulatory peritoneal dialysis.
    Fleming LW; Moreland TA; Scott AC; Stewart WK; White LO
    J Antimicrob Chemother; 1987 Apr; 19(4):493-503. PubMed ID: 3583969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cefmenoxime kinetics during continuous ambulatory peritoneal dialysis.
    Sica DA; Polk RE; Kerkering TM; Patterson P; Baggett J
    Eur J Clin Pharmacol; 1986; 30(6):713-7. PubMed ID: 3464435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients.
    Bastani B; Freer K; Read D; Bailey S; Sherman RA; Davis M; Engels D; Westervelt FB
    Nephron; 1987; 45(4):283-5. PubMed ID: 3587467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pharmacokinetics of cefoperazone in end-stage renal failure patients on peritoneal dialysis].
    Okuda T; Katoh T; Takaichi K; Matsunaga H; Uchida S; Kurokawa K; Nihei H
    Jpn J Antibiot; 1986 Oct; 39(10):2775-9. PubMed ID: 3806960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peritoneal transport of vancomycin during peritoneal dialysis.
    Nielsen HE; Sørensen I; Hansen HE
    Nephron; 1979; 24(6):274-7. PubMed ID: 514426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cefoperazone and sulbactam-related eosinophilic peritonitis: a case report and literature review.
    Wang Z; Li Z; Luo S; Yang Z; Xing Y; Pu C; Dong J
    J Int Med Res; 2021 Jun; 49(6):3000605211025367. PubMed ID: 34162261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Teicoplanin pharmacokinetics and bioavailability during peritoneal dialysis.
    Brouard RJ; Kapusnik JE; Gambertoglio JG; Schoenfeld PY; Sachdeva M; Freel K; Tozer TN
    Clin Pharmacol Ther; 1989 Jun; 45(6):674-81. PubMed ID: 2525081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of intravenous and intraperitoneal cefuroxime in patients undergoing peritoneal dialysis.
    Local FK; Munro AJ; Kerr DN; Sussman M
    Clin Nephrol; 1981 Jul; 16(1):40-3. PubMed ID: 7273495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disposition of ceftazidime after intraperitoneal administration in adolescent patients receiving continuous cycling peritoneal dialysis.
    Sisterhen LL; Stowe CD; Farrar HC; Blaszak CK; Blaszak RT
    Am J Kidney Dis; 2006 Mar; 47(3):503-8. PubMed ID: 16490630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intraperitoneal insulin in uraemic diabetics undergoing continuous ambulatory peritoneal dialysis.
    Balducci A; Slama G; Rottembourg J; Baumelou A; Delage A
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1021-3. PubMed ID: 6794746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.
    Barbhaiya RH; Knupp CA; Pfeffer M; Zaccardelli D; Dukes GM; Mattern W; Pittman KA; Hak LJ
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1387-91. PubMed ID: 1510432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.